TY - JOUR
T1 - Comparison of nuclear grade, necrosis, and histologic subtype between biopsy and resection in pleural malignant mesothelioma
T2 - An international multi-institutional analysis
AU - Schulte, Jefree J.
AU - Chapel, David B.
AU - Attanoos, Richard
AU - Brcic, Luka
AU - Burn, Juliet
AU - Butnor, Kelly J.
AU - Chang, Nina
AU - Chen, Heather
AU - Dacic, Sanja
AU - De Perrot, Marc
AU - Fukuoka, Junya
AU - Galateau-Salle, Francoise
AU - Godschachner, Theresa
AU - Hiroshima, Kenzo
AU - Klebe, Sonja
AU - Krausz, Thomas
AU - Litzky, Leslie
AU - Marchevsky, Alberto M.
AU - Mueller, Jeffrey
AU - Nabeshima, Kazuki
AU - Nicholson, Andrew G.
AU - Pal, Prodipto
AU - Roden, Anja C.
AU - Rorvig, Sara
AU - Santoni-Rugiu, Eric
AU - Tazelaar, Henry
AU - Tsao, Ming Sound
AU - Walts, Ann E.
AU - Weynand, Birgit
AU - Zaizen, Yoshiaki
AU - Zhang, Yu Zhi
AU - Husain, Aliya N.
PY - 2021/12
Y1 - 2021/12
N2 - Objectives: Numerous studies on malignant mesothelioma (MM) highlight the prognostic importance of histologic subtype, nuclear grade, and necrosis. This study compares these parameters in paired biopsy and resection specimens of pleural MM. Methods: Histologic subtype, percentage of epithelioid morphology, nuclear grade, and the presence or absence of necrosis were compared in 429 paired biopsies and resection specimens of pleural MM from 19 institutions. Results: Histologic subtype was concordant in 81% of cases (κ = 0.58). When compared with resection specimens, epithelioid morphology at biopsy had a positive predictive value (PPV) of 78.9% and a negative predictive value (NPV) of 93.5%; sarcomatoid morphology showed high PPV (92.9%) and NPV (99.3%), and biphasic morphology PPV was 89.7% and NPV was 79.7%. Agreement of the percentage of epithelioid morphology was fair (κ = 0.27). Nuclear grade and necrosis were concordant in 75% (κ = 0.59) and 81% (κ = 0.53) of cases, respectively. Nuclear grade showed moderate (κ = 0.53) and substantial (κ = 0.67) agreement from patients with and without neoadjuvant therapy, respectively, and necrosis showed moderate (κ = 0.47 and κ = 0.60) agreement, respectively, in the same subsets of paired specimens. Conclusions: Paired biopsy-resection specimens from pleural MM show overall moderate agreement in pathologic parameters. These findings may help guide postbiopsy management and triage of patients with MM.
AB - Objectives: Numerous studies on malignant mesothelioma (MM) highlight the prognostic importance of histologic subtype, nuclear grade, and necrosis. This study compares these parameters in paired biopsy and resection specimens of pleural MM. Methods: Histologic subtype, percentage of epithelioid morphology, nuclear grade, and the presence or absence of necrosis were compared in 429 paired biopsies and resection specimens of pleural MM from 19 institutions. Results: Histologic subtype was concordant in 81% of cases (κ = 0.58). When compared with resection specimens, epithelioid morphology at biopsy had a positive predictive value (PPV) of 78.9% and a negative predictive value (NPV) of 93.5%; sarcomatoid morphology showed high PPV (92.9%) and NPV (99.3%), and biphasic morphology PPV was 89.7% and NPV was 79.7%. Agreement of the percentage of epithelioid morphology was fair (κ = 0.27). Nuclear grade and necrosis were concordant in 75% (κ = 0.59) and 81% (κ = 0.53) of cases, respectively. Nuclear grade showed moderate (κ = 0.53) and substantial (κ = 0.67) agreement from patients with and without neoadjuvant therapy, respectively, and necrosis showed moderate (κ = 0.47 and κ = 0.60) agreement, respectively, in the same subsets of paired specimens. Conclusions: Paired biopsy-resection specimens from pleural MM show overall moderate agreement in pathologic parameters. These findings may help guide postbiopsy management and triage of patients with MM.
KW - Histology
KW - Malignant mesothelioma
KW - Nuclear grading
UR - http://www.scopus.com/inward/record.url?scp=85108889328&partnerID=8YFLogxK
U2 - 10.1093/ajcp/aqab054
DO - 10.1093/ajcp/aqab054
M3 - Article
C2 - 33978147
AN - SCOPUS:85108889328
SN - 0002-9173
VL - 156
SP - 989
EP - 999
JO - American Journal of Clinical Pathology
JF - American Journal of Clinical Pathology
IS - 6
ER -